SANCTURA
LOE ApproachingNDAORALTABLET
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SANCTURA is an oral small-molecule tablet approved in 2004 for an unknown indication, currently approaching loss of exclusivity. The mechanism of action and specific therapeutic use are not specified in available data. This is a mature NDA product maintained by AbbVie.
LOE Approaching
Product is in late-lifecycle phase with moderate competitive pressure (30/100), indicating smaller brand team and likely focus on efficiency and retention rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial
Started Aug 2010
20 enrolled
Overactive Bladder
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Started Mar 2010
322 enrolled
Overactive Bladder
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial
Started Apr 2009
12 enrolled
ElderlyPharmacokineticsOveractive Bladder
Career Relevance
Zero linked job openings indicate this is a maintenance-phase product with minimal active hiring. Career opportunities are limited to existing team backfill or defensive market management as LOE approaches. Consider this role primarily if seeking stable, mature-product experience rather than growth trajectory.
Worked on SANCTURA at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.